ONMDW OneMedNet Corp - Warrant
$0,03
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla May 15, 2026
52 Haftlık Aralık
$0–$0
0% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
-3.1
ROE
—
Net Kâr Marjı
—
ONMDW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.03
Piyasa Değeri
—
P/E (TTM)
-3.1
EPS (TTM)
$-0.06
Gelir (TTM)
$1M
Temettü Verimi
—
ROE
—
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $0
ONMDW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$1M
2022-12-31
→
2025-12-31
Hisse Başına Kâr
$-0.06
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
—
2023-12-31
→
2024-12-31
Marjlar
—
2023-12-31
→
2024-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ONMDW
Akran Ortalaması
P/E (TTM)
-3.1
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ONMDW
Akran Ortalaması
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ONMDW
Akran Ortalaması
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ONMDW
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
111.3%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
5.6%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ONMDW
Akran Ortalaması
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $1M | $643.0K | $1M | $1M | |
| Cost of Revenue | $2M | $924.0K | $1M | $2M | |
| Gross Profit | $-503.0K | $-281.0K | $-129.0K | $-360.0K | |
| R&D Expense | $2M | $1M | $2M | $2M | |
| SG&A Expense | $6M | $7M | $4M | $5M | |
| Operating Expenses | $9M | $9M | $7M | $7M | |
| Operating Income | $-10M | $-10M | $-7M | $-8M | |
| Interest Expense | · | · | $11.0K | · | |
| Other Non-op | $-16.0K | $-60.0K | $-34.0K | $-23M | |
| Pretax Income | $-3M | $-10M | $-34M | $-30M | |
| Income Tax | $1.0K | $2.0K | $18.0K | $17.0K | |
| Net Income | $-3M | $-10M | $-34M | $-30M | |
| EPS (Basic) | $-0.06 | $-0.36 | $-4.65 | $-7.66 | |
| EPS (Diluted) | $-0.06 | $-0.36 | $-4.65 | $-7.66 | |
| Shares (Basic) | 44,547,815 | 28,076,512 | 7,271,014 | 3,973,897 | |
| Shares (Diluted) | 44,547,815 | 28,076,512 | 7,271,014 | 3,973,897 | |
| EBITDA | · | $-10M | $-7M | $-5M |
Bilanço 23
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $585.0K | $172.0K | $47.0K | $271.0K | |
| Receivables | $495.0K | $213.0K | $152.0K | $19.0K | |
| Prepaid Expense | $509.0K | $385.0K | $166.0K | $101.0K | |
| Current Assets | $2M | $4M | $365.0K | $391.0K | |
| PP&E (Net) | $56.0K | $108.0K | $99.0K | $83.0K | |
| PP&E (Gross) | $338.0K | $324.0K | $307.0K | $263.0K | |
| Accum. Depreciation | $282.0K | $216.0K | $208.0K | $180.0K | |
| Total Assets | $2M | $4M | $464.0K | $1M | |
| Accounts Payable | $3M | $6M | $5M | $1M | |
| Accrued Liabilities | · | · | · | $2M | |
| Short-term Debt | · | $2M | $465.0K | · | |
| Current Liabilities | $5M | $19M | $14M | $26M | |
| Other Non-current Liabilities | · | $449.0K | $68.0K | $44.0K | |
| Total Liabilities | $5M | $20M | $14M | $28M | |
| Long-term Debt | $220.0K | · | $465.0K | · | |
| Total Debt | · | $2M | $2M | · | |
| Common Stock | $5.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $102M | $86M | $78M | $14M | |
| Retained Earnings | $-104M | $-102M | $-91M | $-58M | |
| Treasury Stock | $529.0K | $529.0K | · | · | |
| Stockholders' Equity | $-3M | $-16M | $-13M | $-26M | |
| Liabilities + Equity | $2M | $4M | $464.0K | $1M | |
| Shares Outstanding | 51,796,728 | 27,987,427 | 23,572,232 | 4,033,170 |
Nakit Akışı 11
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $65.0K | $57.0K | $28.0K | $25.0K | |
| Stock-based Comp | $2M | $628.0K | $1M | $2M | |
| Other Non-cash | · | $2M | $27M | · | |
| Operating Cash Flow | $-8M | $-7M | $-5M | $-5M | |
| CapEx | $13.0K | $51.0K | $44.0K | $58.0K | |
| Investing Cash Flow | $2M | $-2M | $-44.0K | $-58.0K | |
| Net Debt Issued | · | $-200.0K | · | · | |
| Financing Cash Flow | $6M | $9M | $5M | $4M | |
| Net Change in Cash | $413.0K | $125.0K | $-224.0K | $-428.0K | |
| Free Cash Flow | · | $-7M | $-5M | · | |
| Levered FCF | · | · | $-5M | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | · | -43.7% | -12.6% | · | |
| Operating Margin | · | -1493.8% | -671.2% | · | |
| Net Margin | · | -1575.3% | -3308.5% | · | |
| Pretax Margin | · | -1575.0% | -3306.8% | · | |
| EBITDA Margin | · | -1484.9% | -668.5% | · | |
| ROA | · | -483.4% | -3854.0% | 0.46% | |
| ROE | · | 67.0% | 110.3% | -3.9% | |
| ROIC | · | 70.5% | 58.1% | 36.8% |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | · | 0.2 | 0.0 | 0.0 | |
| Quick Ratio | · | 0.0 | 0.0 | 0.0 | |
| Debt / Equity | · | -0.1 | -0.1 | · | |
| Interest Coverage | · | · | -623.0 | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | · | 0.3 | 1.2 | · | |
| Receivables Turnover | · | 3.5 | 11.9 | · |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 111.3% | -37.0% | -11.5% | · | |
| Revenue CAGR 3Y | 5.6% | · | · | · |
Değerleme (TTM) 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $1M | $643.0K | $1M | $1M | |
| Net Income TTM | $-3M | $-10M | $-34M | $-30M | |
| P/E | -3.1 | · | · | · | |
| Earnings Yield | -32.6% | · | · | · |
Gelir Tablosu 17
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $96.0K | $890.0K | $177.0K | $155.0K | $137.0K | $26.0K | $142.0K | $227.0K | $248.0K | $322.0K | $326.0K | $173.0K | $200.0K | $264.0K | |
| Cost of Revenue | $476.0K | $706.0K | $399.0K | $396.0K | $361.0K | $52.0K | $226.0K | $329.0K | $317.0K | $338.0K | $293.0K | $230.0K | $289.0K | $406.7K | |
| Gross Profit | $-380.0K | $184.0K | $-222.0K | $-241.0K | $-224.0K | $-26.0K | $-84.0K | $-102.0K | $-69.0K | $-16.0K | $33.0K | $-57.0K | $-89.0K | $-142.7K | |
| R&D Expense | $311.0K | $462.0K | $323.0K | $382.0K | $348.0K | $341.0K | $298.0K | $383.0K | $445.0K | $499.0K | $405.0K | $579.0K | $582.0K | $880.6K | |
| SG&A Expense | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $1M | $624.0K | $539.0K | $3M | |
| Operating Expenses | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $4M | |
| Operating Income | $-3M | $-3M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-6M | |
| Interest Expense | · | · | · | · | · | · | $14.0K | $15.0K | $25.0K | · | · | · | · | · | |
| Other Non-op | $99.0K | $-60.0K | $-8.0K | $-12.0K | $322.0K | $-43.0K | $-4.0K | $-20.0K | $7.0K | $10.0K | $-7.0K | $-29.0K | $-8.0K | $-22M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | $-33M | $-728.8K | $57.5K | $-26.4K | $-34M | |
| Income Tax | · | · | · | · | · | · | · | · | · | $-192.0K | $87.7K | $62.7K | $59.6K | $-89.7K | |
| Net Income | $-2M | $-3M | $-741.0K | $3M | $-2M | $-2M | $-2M | $-4M | $-2M | $-2M | $-14M | $-10M | $-8M | $-33M | |
| EPS (Basic) | $-0.04 | $-0.06 | $-0.01 | $0.07 | $-0.06 | $-0.07 | $-0.07 | $-0.14 | $-0.08 | $2.90 | $-3.23 | $-2.38 | $-1.94 | $-9.10 | |
| EPS (Diluted) | $-0.04 | $-0.06 | $-0.01 | $0.07 | $-0.06 | $-0.07 | $-0.07 | $-0.14 | $-0.08 | $2.90 | $-3.23 | $-2.38 | $-1.94 | $-8.10 | |
| Shares (Basic) | 55,316,371 | -79,009,885 | 52,618,031 | 36,835,945 | 34,103,724 | -51,291,765 | 29,265,023 | 25,180,764 | 24,922,490 | -5,076,103 | 4,280,777 | 4,033,170 | 4,033,170 | -4,591,156 | |
| Shares (Diluted) | 55,316,371 | -80,579,861 | 52,618,031 | 38,405,921 | 34,103,724 | -51,291,765 | 29,265,023 | 25,180,764 | 24,922,490 | -5,076,103 | 4,280,777 | 4,033,170 | 4,033,170 | -4,591,156 | |
| EBITDA | $-3M | · | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-918.5K | $-285.5K | $-353.8K | · |
Bilanço 23
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $233.0K | $585.0K | $149.0K | $122.0K | $144.0K | $172.0K | $2M | $407.0K | $174.0K | $47.0K | $1.5K | $3.4K | $10.1K | $271.0K | |
| Receivables | $697.0K | $495.0K | $582.0K | $254.0K | $247.0K | $213.0K | $63.0K | $75.0K | $253.0K | $152.0K | $86.4K | · | · | $19.0K | |
| Prepaid Expense | $464.0K | $509.0K | $115.0K | $293.0K | $447.0K | $385.0K | $151.0K | $174.0K | $229.0K | $166.0K | $21.6K | · | · | $101.0K | |
| Current Assets | $1M | $2M | $1M | $2M | $2M | $4M | $4M | $956.0K | $656.0K | $365.0K | $23.1K | $3.4K | $10.1K | $391.0K | |
| PP&E (Net) | $47.0K | $56.0K | $60.0K | $70.0K | $101.0K | $108.0K | $84.0K | $85.0K | $94.0K | $99.0K | $5M | · | · | $83.0K | |
| PP&E (Gross) | · | $338.0K | · | · | · | $324.0K | · | · | · | $307.0K | $291.8K | · | · | $263.0K | |
| Accum. Depreciation | · | $282.0K | · | · | · | $216.0K | · | · | · | $208.0K | $199.4K | · | · | $180.0K | |
| Total Assets | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $1M | $750.0K | $464.0K | $19M | $30M | $30M | $1M | |
| Accounts Payable | $4M | $3M | $4M | $5M | $7M | $6M | $6M | $6M | $6M | $5M | $1M | · | · | $1M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | $3M | · | · | · | |
| Short-term Debt | · | · | · | · | $2M | · | $2M | · | · | $465.0K | · | · | · | · | |
| Current Liabilities | $5M | $5M | $5M | $6M | $18M | $19M | $19M | $20M | $15M | $14M | $3M | $2M | $2M | $26M | |
| Other Non-current Liabilities | · | · | $440.0K | $18.0K | $128.0K | · | $28.0K | $22.0K | $16.0K | $68.0K | · | $3M | · | $44.0K | |
| Total Liabilities | $6M | $5M | $5M | $6M | $18M | $20M | $19M | $20M | $16M | $14M | $12M | $10M | $10M | $28M | |
| Long-term Debt | $176.0K | $220.0K | · | · | $2M | · | $2M | $2M | · | $465.0K | · | · | · | · | |
| Total Debt | · | · | · | · | $2M | · | $2M | · | · | · | · | · | · | · | |
| Common Stock | $5.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $455 | · | · | · | |
| Paid-in Capital | $103M | $102M | $98M | $97M | $87M | $86M | $85M | $78M | $78M | $78M | $917.5K | $2M | $2M | $14M | |
| Retained Earnings | $-107M | $-104M | $-101M | $-100M | $-103M | $-102M | $-99M | $-97M | $-94M | $-91M | $-13M | $-12M | $-12M | $-58M | |
| Treasury Stock | $529.0K | $529.0K | $529.0K | $529.0K | $529.0K | $529.0K | $529.0K | $529.0K | $529.0K | · | · | · | · | · | |
| Stockholders' Equity | $-4M | $-3M | $-4M | $-4M | $-17M | $-16M | $-14M | $-19M | $-16M | $-13M | $-12M | $-10M | $-9M | $-26M | |
| Liabilities + Equity | · | $2M | $2M | $2M | $2M | $4M | $4M | $1M | $750.0K | $464.0K | $19M | $30M | $30M | $1M | |
| Shares Outstanding | 52,791,966 | 51,984,474 | 49,725,274 | 46,095,647 | 30,572,831 | 27,987,427 | 27,987,427 | 23,862,265 | 23,662,265 | 23,572,232 | 4,550,166 | · | · | 4,033,170 |
Nakit Akışı 10
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $11.0K | $9.0K | $10.0K | $34.0K | $12.0K | $26.0K | $10.0K | $10.0K | $11.0K | $9.0K | $6.0K | $7.0K | $6.0K | $8.7K | |
| Stock-based Comp | $431.0K | $1M | $142.0K | $197.0K | $208.0K | $181.0K | $207.0K | $103.0K | $137.0K | $29.0K | $798.0K | $280.0K | $368.0K | $2M | |
| Other Non-cash | $469.0K | · | · | · | $-266.0K | · | · | · | $414.0K | · | · | · | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-4M | |
| CapEx | $2.0K | $5.0K | $0 | $3.0K | $5.0K | $35.0K | $9.0K | $1.0K | $6.0K | $16.0K | $21.0K | · | · | $9.2K | |
| Investing Cash Flow | $352.0K | $-51.0K | $1M | $-670.0K | $2M | $365.0K | $-2M | $-1.0K | $-6.0K | $-16.0K | $250.8K | $361.8K | · | $2M | |
| Stock Issued | · | · | $500.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $838.0K | $2M | $477.0K | $3M | $-94.0K | $-131.0K | $5M | $2M | $2M | $1M | $3M | $2M | $876.0K | $2M | |
| Net Change in Cash | $-352.0K | $436.0K | $27.0K | $-22.0K | $-28.0K | $-2M | $1M | $533.0K | $127.0K | $-565.0K | $368.4K | $61.8K | $-126.0K | $-209.8K | |
| Free Cash Flow | $-2M | · | · | · | $-2M | · | · | · | $-2M | · | · | · | · | · |
Kârlılık 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -395.8% | · | -125.4% | -155.5% | -163.5% | · | -59.2% | -44.9% | -27.8% | · | · | · | · | · | |
| Operating Margin | -2658.3% | · | -1262.7% | -1331.0% | -1623.4% | · | -1681.0% | -1081.1% | -847.2% | · | · | · | · | · | |
| Net Margin | -2555.2% | · | -418.6% | 1923.9% | -1388.3% | · | -1449.3% | -1581.1% | -850.4% | · | · | · | · | · | |
| EBITDA Margin | -2646.9% | · | -1262.7% | -1331.0% | -1614.6% | · | -1681.0% | -1081.1% | -842.7% | · | · | · | · | · | |
| ROA | -151.5% | · | -25.1% | 176.6% | -153.3% | · | -17.3% | -23.1% | -13.8% | · | -1.2% | -0.01% | -0.12% | · | |
| ROE | 23.8% | · | 8.1% | -25.9% | 11.8% | · | 15.9% | 24.5% | 16.8% | · | 8.1% | 0.06% | 1.1% | · | |
| ROIC | · | · | · | · | · | · | · | · | · | · | 8.8% | -0.25% | 12.2% | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.3 | · | 0.3 | 0.4 | 0.1 | · | 0.2 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | |
| Quick Ratio | 0.2 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | |
| Debt / Equity | · | · | · | · | -0.1 | · | -0.2 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | -170.5 | -163.6 | -84.0 | · | · | · | · | · |
Verimlilik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | |
| Receivables Turnover | 0.2 | · | 0.5 | 0.9 | 0.5 | · | 1.9 | 6.1 | 2.0 | · | · | · | · | · |
Değerleme (TTM) 9
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $565.0K | · | $611.0K | $661.0K | $754.0K | · | $943.0K | $974.0K | $947.0K | · | · | · | · | · | |
| Net Income TTM | $-2M | · | $-2M | $-5M | $-10M | · | $-22M | $-29M | $-33M | · | $-31M | $-17M | $-5M | · | |
| Market Cap | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.9 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 6.9 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | -1.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -2.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | -2.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -54.0% | · | · | · | · | · | · | · | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $1M | $643.0K | $1M | $1M | — |
| Brüt Kâr Marjı % | — | -43.7% | -12.6% | — | — |
| Faaliyet Kâr Marjı % | — | -1493.8% | -671.2% | — | — |
| Net Gelir | $-3M | $-10M | $-34M | $-30M | $5M |
| Seyreltilmiş Hisse Başı Kâr | $-0.06 | $-0.36 | $-4.65 | $-7.66 | $0.44 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | — | -0.1 | -0.1 | — | — |
| Cari Oran | — | 0.2 | 0.0 | 0.0 | 1.8 |
| Cari Oran | — | 0.0 | 0.0 | 0.0 | 1.6 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | — | $-7M | $-5M | — | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 15 dosya · $190K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 1 (-1 önceki Ç'ye göre) | 1 (+1 önceki Ç'ye göre) | 1 (-1 önceki Ç'ye göre) | 2 (0 önceki Ç'ye göre) | +686K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| TORONTO DOMINION BANK | $101.993 | 2.914.096 | 53,55% | Hisse senetleri |
| Savant Capital, LLC | $30.947 | 871.744 | 16,25% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $15.204 | 420.000 | 7,98% | Hisse senetleri |
| Yakira Capital Management, Inc. | $11.468 | 330.494 | 6,02% | Hisse senetleri |
| Polar Asset Management Partners Inc. | $9.069 | 256.916 | 4,76% | Hisse senetleri |
| Clear Street Derivatives LLC | $6.499 | 240.717 | 3,41% | Hisse senetleri |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | $4.631 | 128.631 | 2,43% | Hisse senetleri |
| Clear Street Group Inc. | $2.906 | 83.747 | 1,53% | Hisse senetleri |
| CLEAR STREET LLC | $2.241 | 83.013 | 1,18% | Hisse senetleri |
| Hunting Hill Global Capital, LLC | $2.190 | 30.200 | 1,15% | Hisse senetleri |
| WHITEBOX ADVISORS LLC | $1.725 | 49.700 | 0,91% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $868 | 25.000 | 0,46% | Alım opsiyonu |
| TWO SIGMA SECURITIES, LLC | $658 | 19.086 | 0,35% | Hisse senetleri |
| UBS Group AG | $69 | 1.984 | 0,04% | Hisse senetleri |
| SkyView Investment Advisors, LLC | $9 | 144.389 | 0,00% | Hisse senetleri |
Şirket yöneticileri 3 içeriden öğrenenler · 2 yöneticiler · 2 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Aaron Green | Chief Executive Officer | 23 Haziran 2026 P | 1.896.375 | 3 | 0 | $51.664 |
| Jeffrey Yu | Chief Medical Officer | 23 Haziran 2026 P | 8.780.410 | 2 | 0 | $200.000 |
| Thomas Kosasa | — | 30 Temmuz 2026 P | 18.538.150 | 2 | 0 | $1.100.000 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış